Annabell Szymansky
Berlin, BE 13353, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.
Journal: Cancers
Published: December 10, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma.
Journal: Cancer research communications
Published: November 23, 2024
Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.
Journal: Journal of clinical medicine
Published: September 11, 2024
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis.
Journal: Journal of clinical medicine
Published: August 11, 2024
Mutational topography reflects clinical neuroblastoma heterogeneity.
Journal: Cell genomics
Published: April 28, 2023
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN.
Journal: Nature communications
Published: June 07, 2022
Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 20, 2021
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing.
Journal: Journal of personalized medicine
Published: May 14, 2021
Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions.
Journal: Nature communications
Published: November 23, 2020
Publisher Correction: Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma.
Journal: Nature genetics
Published: February 29, 2020
Last Updated: 09/26/2026